class name | count |
---|---|
Magnoliophyta | 4 |
Embryophyta | 1 |
Spermatophyta | 1 |
class name | count |
---|---|
Magnoliaceae | 4 |
Herbertaceae | 1 |
Pinaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00001259
![]() |
Naphthalene
|
CHEMBL16293
|
C031721
|
6 / 5 / 4 | 43 / 18 |
![]() |
C00042269
![]() |
Azulene
|
C005525
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P42574 | Caspase-3 | C14 | C00001259 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001259 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001259 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001259 | 2 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001259 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00001259 | 3 / 4 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001259
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00001259
|
429 | ASCL1, ASH1, HASH1, MASH1, bHLHa46 | achaete-scute family bHLH transcription factor 1 |
C00001259
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001259
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001259
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001259
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001259
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001259
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001259
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00001259
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001259
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001259
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001259
|
13107 |
C00001259
|
||
29785 | CYP2S1 | cytochrome P450, family 2, subfamily S, polypeptide 1 (EC:1.14.14.1) |
C00001259
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001259
|
1577 | CYP3A5, CP35, CYPIIIA5, P450PCN3, PCN3 | cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) |
C00001259
|
2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00001259
|
2053 | EPHX2, CEH, SEH | epoxide hydrolase 2, cytoplasmic (EC:3.3.2.10 3.1.3.76) |
C00001259
|
2252 | FGF7, HBGF-7, KGF | fibroblast growth factor 7 |
C00001259
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001259
|
2521 | FUS, ALS6, ETM4, FUS1, HNRNPP2, POMP75, TLS | fused in sarcoma |
C00001259
|
2642 | GCGR, GGR | glucagon receptor |
C00001259
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001259
|
8870 | IER3, DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 | immediate early response 3 |
C00001259
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00001259
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001259
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001259
|
3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00001259
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00001259
|
4159 | MC3R, BMIQ9, MC3, MC3-R, OB20, OQTL | melanocortin 3 receptor |
C00001259
|
4160 | MC4R | melanocortin 4 receptor |
C00001259
|
4161 | MC5R, MC2 | melanocortin 5 receptor |
C00001259
|
10403 | NDC80, HEC, HEC1, HsHec1, KNTC2, TID3, hsNDC80 | NDC80 kinetochore complex component |
C00001259
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001259
|
5053 | PAH, PH, PKU, PKU1 | phenylalanine hydroxylase (EC:1.14.16.1) |
C00001259
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00001259
|
389 | RHOC, ARH9, ARHC, H9, RHOH9 | ras homolog family member C |
C00001259
|
7356 | SCGB1A1, CC10, CC16, CCPBP, CCSP, UGB, UP-1, UP1 | secretoglobin, family 1A, member 1 (uteroglobin) |
C00001259
|
6855 | SYP, MRXSYP | synaptophysin |
C00001259
|
6932 | TCF7, TCF-1 | transcription factor 7 (T-cell specific, HMG-box) |
C00001259
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00001259
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001259
|
OMIM | preferred title | UniProt |
---|---|---|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#114500 | Colorectal cancer; crc |
P18054
|
#133239 | Esophageal cancer |
P18054
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
KEGG | name | UniProt |
---|---|---|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000014 | Abnormalities, Drug-Induced |
C00001259
|
D058186 | Acute Kidney Injury |
C00001259
|
D055371 | Acute Lung Injury |
C00001259
|
D000743 | Anemia, Hemolytic |
C00001259
|
D002386 | Cataract |
C00001259
|
D006456 | Hemoglobinuria |
C00001259
|
D006529 | Hepatomegaly |
C00001259
|
D006959 | Hyperoxaluria |
C00001259
|
D006965 | Hyperplasia |
C00001259
|
D008114 | Liver Neoplasms, Experimental |
C00001259
|
D055370 | Lung Injury |
C00001259
|
D008175 | Lung Neoplasms |
C00001259
|
D048629 | Micronuclei, Chromosome-Defective |
C00001259
|
D009336 | Necrosis |
C00001259
|
D009362 | Neoplasm Metastasis |
C00001259
|
D011041 | Poisoning |
C00001259
|
D014133 | Tracheal Diseases |
C00001259
|
D015431 | Weight Loss |
C00001259
|